Delivery Order 36F79722D0161-36C26026F0059
Award Date
11/1/25
Potential Completion Date
10/31/26
Potential Value
$311K
Federal Agency
Veterans Integrated Service Network 20
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brookhaven, NY 11719, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Amneal Pharmaceuticals Of New York, LLC (doing business as Amneal Pharmaceuticals) for the supply of XYREM (sodium oxybate) oral solution. The $173,571.00 contract, issued under the GSA Multiple Award Schedule for Pharmaceuticals and Drugs, has an ultimate completion date of October 31, 2025. Amneal, a for-profit limited liability company that manufactures pharmaceuticals and drugs, has also been...
The U.S. Department of Veterans Affairs (VA) has awarded a $185,400.49 firm fixed price delivery order to Amneal Pharmaceuticals of New York, LLC, doing business as Amneal Pharmaceuticals, for the provision of the generic drug sodium oxybate (the active ingredient in Xyrem). This delivery order was placed under Amneal's existing GSA Multiple Award Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has an ultimate completion date of October 31, 2024. Amneal...
This contract award is for the delivery of the drug Xyrem (sodium oxybate) 500mg/ml to the Veterans Health Administration, which is part of the U.S. Department of Veterans Affairs. The contract was awarded to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company that provides specialty medications to the federal government, primarily the VA. The contract is a Blanket Purchase Agreement (BPA) call order issued under Jazz Pharmaceuticals' Federal Supply Schedule (FSS) contract for...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, to provide the specialty medication Xyrem. The $53,357.40 firm fixed price delivery order was placed under Jazz Pharmaceuticals' $150 million Blanket Purchase Agreement and $116 million Federal Supply Schedule contract for the Pharmaceuticals and Drugs product category. The contract supports the VA's provision of healthcare services...
This is a federal contract award to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of the pharmaceutical product XYREM, a medication used to treat narcolepsy and sleep disorders. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $210,000.00 and a performance period ending on September 30, 2026. The contract is awarded under the Pharmaceuticals and Drugs Federal Supply...
This is a federal contract award to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of the oral medication Xyrem, a specialty pharmaceutical product used to treat sleep disorders. The award is under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows the VA to efficiently procure needed medications for its medical facilities nationwide. The contract is a...
This is a contract award to Jazz Pharmaceuticals, Inc. by the Department of Veterans Affairs Veterans Health Administration (VA VHA) for the delivery of the specialty pharmaceutical Xyrem. The contract is a Blanket Purchase Agreement (BPA) Call and a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule, allowing the VA to efficiently procure needed medications. The total potential value of the contract is $180,137.37, with no set-aside designation. Jazz...
The Department of Veterans Affairs (VA) awarded a firm fixed price Blanket Purchase Agreement (BPA) call order to Jazz Pharmaceuticals, Inc. for the delivery of the specialty pharmaceutical Xyrem. The BPA, valued at up to $122,534.37, was issued through the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) contract to support the procurement of needed medications for VA medical facilities. The contract does not have a set-aside designation. The order was placed by the VA's...
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jazz Pharmaceuticals, Inc. for the provision of Xyrem medication to the Durham VA Medical Center Pharmacy. The contract is a firm fixed price type, with a ceiling value of $547,993.80. It was awarded on October 1, 2016 and has an ultimate completion date of December 12, 2017. The contract is placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allowing the VA to...
This federal contract award is for the delivery of the specialty pharmaceutical product XYREM to the Department of Veterans Affairs (VA) Veterans Health Administration. The prime contractor is Jazz Pharmaceuticals, Inc., a global biopharmaceutical company that provides medications to the federal government, primarily the VA. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a firm fixed price of $46,346.90 and a completion date of...